Duyuru • May 30
Veeva Systems Announces Falcon Agentic Platform And Standard Agents For Drug Development Veeva Systems announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes. Falcon works with Veeva Development Cloud applications in clinical, regulatory, and safety to reduce cost, increase speed, and maintain compliance for biopharmas of all sizes. The initial focus areas are trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake. Planned for early adopter availability in November 2026, Falcon is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences. Duyuru • May 14
Veeva Systems Inc. to Report Q1, 2027 Results on Jun 03, 2026 Veeva Systems Inc. announced that they will report Q1, 2027 results After-Market on Jun 03, 2026 Duyuru • May 06
Veeva Systems Inc., Annual General Meeting, Jun 17, 2026 Veeva Systems Inc., Annual General Meeting, Jun 17, 2026. New Risk • May 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Duyuru • Mar 11
Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million. Veeva Systems Inc. (NYSE:VEEV) acquired Rise Healthcare Tech, Inc from group of shareholders for $100 Million on March 10, 2026. Ostro will operate as an independent unit led by CEO Chase Feiger.
Veeva Systems Inc. (NYSE:VEEV) completed the acquisition of Rise Healthcare Tech, Inc from group of shareholders on March 10, 2026. Reported Earnings • Mar 05
Full year 2026 earnings released: EPS: US$5.55 (vs US$4.41 in FY 2025) Full year 2026 results: EPS: US$5.55 (up from US$4.41 in FY 2025). Revenue: US$3.20b (up 16% from FY 2025). Net income: US$908.9m (up 27% from FY 2025). Profit margin: 28% (up from 26% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe. Duyuru • Mar 05
Veeva Systems Inc. Provides Earnings Guidance for the First Quarter Ending April 30, 2026 and Fiscal Year Ending January 31, 2027 Veeva Systems Inc. provided earnings guidance for the first quarter ending April 30, 2026 and fiscal year ending January 31, 2027. For the quarter, the company expected total revenues between $855 and $858 million.
For the year 2027, the company expected total revenues between $3,585 and $3,600 million. Duyuru • Feb 12
Veeva Systems Inc. to Report Q4, 2026 Results on Mar 04, 2026 Veeva Systems Inc. announced that they will report Q4, 2026 results After-Market on Mar 04, 2026 New Risk • Feb 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Buy Or Sell Opportunity • Jan 27
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 26% to €183. The fair value is estimated to be €230, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Duyuru • Jan 08
Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing Veeva Systems announced a new environmental monitoring (EM) solution to advance quality control (QC) for manufacturing operations. Veeva Environmental Monitoring, a cloud-native application unified with Veeva LIMS, will enable laboratories and manufacturing facilities to schedule, collect, and analyze environmental samples to ensure compliance with GMP and internal sterility standards. Part of Veeva Quality Cloud, Veeva Environmental Monitoring will seamlessly integrate with Veeva quality applications to eliminate data silos and paper-based processes that slow batch release. With unified QC, users can automatically initiate quality events in Veeva QMS, surface procedures from Veeva QualityDocs, and publish critical environmental monitoring data to Veeva Batch Release to optimize the batch release process. Duyuru • Jan 06
Veeva Systems Inc. (NYSE:VEEV) announces an Equity Buyback for $2,000 million worth of its shares. Veeva Systems Inc. (NYSE:VEEV) announces an share repurchase program. Under the program, the company will repurchases up to $2,000 million worth of its Class A common stock. The program has a term of 2 years, does not obligate Veeva to acquire a specific number of shares of Class A common stock, and may be canceled or suspended at any time without notice. Duyuru • Dec 13
Veeva Systems Inc. Appoints Vipin Kondath as Principal Accounting Officer, Effective December 12, 2025 On December 10, 2025, the board of directors of Veeva Systems Inc. appointed Vipin Kondath as its principal accounting officer, effective December 12, 2025. Vipin Kondath, age 50, has served as Veeva’s VP, Corporate Controller since April 2022. From August 2019 to March 2022, he served as Veeva’s Senior Director of Revenue Accounting. Mr. Kondath holds a Bachelor of Commerce degree from Mahatma Gandhi University, and is a chartered accountant from India and a certified public accountant in the State of California. Mr. Kondath also entered into Veeva’s standard form of indemnification agreement and there was no change to his compensation arrangements as a result of the appointment. Buy Or Sell Opportunity • Dec 12
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 19% to €191. The fair value is estimated to be €244, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Duyuru • Dec 03
Veeva Systems Announces the Availability of Veeva Ai Agents for Vault CRM and PromoMats Veeva Systems announced the availability of Veeva AI Agents for Vault CRM and PromoMats. Veeva AI in the Veeva Vault Platform and deep, specialized AI agents working in Veeva applications deliver practical AI with clear business value. Additional Veeva AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026. Veeva AI Now Available for Vault CRM: Free Text Agent detects and flags potential issues in call notes to ensure accuracy and compliance. With more in-depth call reporting, companies gain the advantage of richer, higher quality customer insights. Voice Agent enables voice input for Vault CRM so it's faster and easier for field teams to capture information and follow-up actions. Pre-call Agent provides insights and suggested actions from relevant data, content, activity, and trends that help field reps prepare for calls. Veeva AI Now available for PromoMats: Quick Check Agent scans content using editorial, brand, market, channel, and compliance guidelines to address issues before medical, legal, regulatory (MLR) review. Content Agent provides context-aware insights into document text and images, answers questions, summarizes content, analyzes visuals, and draws from Quick Check Agent to assist with document review. Veeva AI Agents work seamlessly within Veeva applications and have direct, secure access to data, documents, and workflows and operate within established user access controls, permissions, and audit trails. Customers can also configure and extend Veeva-delivered AI Agents and build their own custom agents with Veeva AI. Veeva Business Consulting provides support for the business process design and change management necessary as companies define new business and process flows among users and agents. Buy Or Sell Opportunity • Nov 25
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to €206. The fair value is estimated to be €258, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 21%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Reported Earnings • Nov 21
Third quarter 2026 earnings released: EPS: US$1.44 (vs US$1.15 in 3Q 2025) Third quarter 2026 results: EPS: US$1.44 (up from US$1.15 in 3Q 2025). Revenue: US$811.2m (up 16% from 3Q 2025). Net income: US$236.2m (up 27% from 3Q 2025). Profit margin: 29% (up from 27% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe. Duyuru • Nov 21
Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ending January 31, 2026 and Updates Earnings Guidance for the Fiscal Year Ending January 31, 2026 Veeva Systems Inc. provides earnings guidance for the fiscal fourth quarter ending January 31, 2026 and updates earnings guidance for the fiscal year ending January 31, 2026. For the quarter, the company expects total revenues between $807 million and $810 million.
The company is providing updated guidance for its fiscal year ending January 31, 2026 as follows: Total revenues between $3,166 and $3,169 million. Duyuru • Nov 19
Veeva Systems Inc. Announces Executive Changes On November 17, 2025, Kristine Diamond, Chief Accounting Officer, informed Veeva Systems Inc. of her decision to resign from her position effective as of December 11, 2025. Upon Ms. Diamond’s departure, Brian Van Wagener, Chief Financial Officer of Veeva, will serve as principal accounting officer until a replacement is named. Duyuru • Oct 31
Veeva Systems Inc. to Report Q3, 2026 Results on Nov 20, 2025 Veeva Systems Inc. announced that they will report Q3, 2026 results After-Market on Nov 20, 2025 Board Change • Oct 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 06
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 28
Second quarter 2026 earnings released: EPS: US$1.23 (vs US$1.06 in 2Q 2025) Second quarter 2026 results: EPS: US$1.23 (up from US$1.06 in 2Q 2025). Revenue: US$789.1m (up 17% from 2Q 2025). Net income: US$200.3m (up 17% from 2Q 2025). Profit margin: 25% (in line with 2Q 2025). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe. Duyuru • Aug 07
Veeva Systems Inc. to Report Q2, 2026 Results on Aug 27, 2025 Veeva Systems Inc. announced that they will report Q2, 2026 results at 4:00 PM, US Eastern Standard Time on Aug 27, 2025 Board Change • Jul 21
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Jun 25
Grunenthal Advances Global Regulatory Information Management and Operations with Veeva RIM Veeva Systems announced that Grunenthal is advancing its global regulatory organization with Veeva RIM. By streamlining regulatory information management (RIM) on a single, cloud-based platform, Grunenthal can respond faster to changing regulations and increase process efficiency, from submission planning to health authority submissions to tracking of approvals and decisions. Grunenthal is a leader in pain management focused on addressing unmet medical needs worldwide. With Veeva RIM, the company gains stronger alignment across global regulatory teams, improved data oversight, and the flexibility to scale. By bringing all cross-functional regulatory processes and information together in one application, teams can efficiently respond to regulatory needs and ensure ongoing compliance globally. Board Change • Jun 25
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • May 29
First quarter 2026 earnings released: EPS: US$1.40 (vs US$1.00 in 1Q 2025) First quarter 2026 results: EPS: US$1.40 (up from US$1.00 in 1Q 2025). Revenue: US$759.0m (up 17% from 1Q 2025). Net income: US$228.2m (up 41% from 1Q 2025). Profit margin: 30% (up from 25% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe. Duyuru • May 29
Veeva Systems Inc. Provides Earnings Guidance for the Second Quarter Ending July 31, 2025 and Fiscal Year Ending January 31, 2026 Veeva Systems Inc. provided earnings guidance for the second quarter ending July 31, 2025 and updated earnings guidance fiscal year ending January 31, 2026. For the second quarter, the company expects total revenues between $766 million and $769 million.
For the full year, the company expects total revenues between $3,090 million and $3,100 million. Board Change • May 19
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Marshall Mohr was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • May 08
Veeva Systems Inc. to Report Q1, 2026 Results on May 28, 2025 Veeva Systems Inc. announced that they will report Q1, 2026 results After-Market on May 28, 2025 Duyuru • May 06
Veeva Systems Inc., Annual General Meeting, Jun 18, 2025 Veeva Systems Inc., Annual General Meeting, Jun 18, 2025. 
